Mycophenolate mofetil
Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy
... 34. Opelz G, Zeier M, Laux G, Morath C, Dohler B. No improve- ment of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a ...
8
Does Mycophenolate Mofetil Increase the Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients? – A Mini-Review
... European Mycophenolate Mofetil Cooperative Study comprised 491 recipients of cadaveric renal allografts divided into three groups: all received cyclosporine and corticosteroids, and the three arms received ...
7
Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient
... Acute pancreatitis is a rare life-threatening complication in patients after kidney transplantation. Here we described a 56-year-old man who had received a living related kidney transplant for an end-stage renal disease. ...
3
Granulomatose de Wegener Intolerante a Ciclofosfamida tratada com sucesso com Micofenolato Mofetil.
... Three and a half months later, the CRP had nor- malized (0.2 mg/dL) and the ESR had decreased to 32 mm/h. Proteinuria (6.1 g/day) and active uri- nary sediment persisted; serum creatinine re- mained stable at the ...
5
Avaliação dos imunossupressores micofenolato mofetil, sirolimo e tacrolimo usados no tratamento de manutenção de transplantes renais realizados no Sistema Único de Saúde do Brasil entre 2000 e 2006
... including mycophenolate mofetil, and sirolimus, but the data are not consolidated enough to allow clear conclusions regarding the efficacy and safety of these drugs and differences as regards the survival ...
130
Int. braz j urol. vol.40 número2
... Nowadays the association of a calcineurin inhibitor (CNI) with Mycophenolate mofetil (MMF) represents the backbone of solid-organ transplant immunosuppression. Although CNIs [Cyclosporine A (CsA) and ...
9
Dermatose por IgA e IgG linear: relato de caso com boa resposta terapêutica à dapsona e ao micofenolato mofetil.
... Abstract: A 21-year-old female presenting linear IgA and IgG disease initially responded well to dapsone thera- py. However, the treatment with dapsone was withdrawn due to severe anemia induced by malaria, which led to ...
4
HEALTHCARE-RELATED INFECTIONS AND FACTORS ASSOCIATED TO THE POSTOPERATIVE PERIOD OF LIVER TRANSPLANTATION
... of mycophenolate mofetil immunosuppressant and the average use of some invasive devices were identified as the factors associated with the occurrence of infections, being statistically significant for ...
12
Uso de micofenolato mofetil em pacientes com lúpus eritematoso sistêmico juvenil e nefrite refratária.
... The mycophenolate mofetil ( MMF ) is an immunosuppressive drug used in the treatment of autoimmune diseases including juvenile systemic lupus erythematosus, especially in cases of lupus nephritis refractory ...
7
Monitoramento terapêutico do ácido micofenólico: validação de método e análise de interação com omeprazol
... Mycophenolic acid (MPA) is an active immunosuppressant molecule to prevent solid organ transplants acute rejection. It is commercially available either as the ester prodrug Mycophenolate Mofetil (MMF) ...
96
Avaliação da tolerabilidade do micofenolato sódico com revestimento entérico versus micofenolato mofetil em receptores de transplante renal.
... Introduction: Mycophenolate mofetil (MMF), pro-drug mycophenolic acid (MPA) is an immunosuppressive effective in the prophylaxis of acute rejection, but associated with gastrointestinal adverse ...events. ...
6
Arq. Bras. Oftalmol. vol.67 número6
... Report on the effect of oral mycophenolate mofetil (MMF) on the treatment of a patient with active birdshot chorioretinopathy (BC) refractory to azathioprine (AZA) therapy. A sixty-two-year-old female ...
3
Acometimento pulmonar e cardíaco em doença de Still do adulto e resposta à imunoglobulina intravenosa
... Adult onset Still's disease and collapsing glomerulonephropathy: successful treatment with intravenous immunoglo- bulins and mycophenolate mofetil. Emmenegger U, Frey U, Reimers A et al[r] ...
5
Rev. Bras. Reumatol. vol.52 número2 en v52n2a13
... The Sjögren’s syndrome (SS) is an autoimmune disease characterized by a lymphocytic infi ltration of salivary and lacrimal glands. Hematological manifestations of primary SS (pSS) usually consist of mild anemia, ...
4
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa.
... (Mycophenolate mofetil for childhood PAN) is an open-label non-infe- riority RCT of mycophenolate mofetil (MMF) versus CYC for the treatment of PAN in chil- dren (4–18 years), currently being ...
14
Arq. Bras. Oftalmol. vol.79 número6
... Purpose: To evaluate the eicacy and tolerance of mycophenolate mofetil (MMF) for the treatment of noninfectious uveitis using the methods advocated by the Standar- dization of Uveitis [r] ...
4
Clinics vol.66 número8
... In the present study, we tested a drug that is commonly used as part of the immunosuppressant triple therapy regimen that consists of a corticosteroid (prednisone, prednisolone, or methylprednisolone), a calcineurin ...
5
Rev. Assoc. Med. Bras. vol.62 suppl.1
... Etarnecept, mycophenolate, denileukin or pentostatin plus corticosteroids for acute graft- versus-host disease:a randomized phase 2 trial from the Blood and Marrow Transplant Clinical [r] ...
7
Micofenolato mofetil na síndrome de Sjögren primária: uma opção para o tratamento da agranulocitose.
... A síndrome de Sjögren (SS) é uma doença autoimune caracterizada pela presença de infi ltrado linfocítico nas glândulas salivares e lacrimais. Manifestações hematológicas da síndrome de Sjögren primária (SSp) geralmente ...
3